McManus, H. D., Appukkuttan, S., Liao, N., Goel, H., Kalayeh, B., Arango-Hisijara, I. (2026). Discontinuation rates among patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating novel androgen receptor inhibitors in oncology and non-oncology settings.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.105